Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000241566 | SCV000302565 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000241566 | SCV000512998 | benign | not specified | 2015-09-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV001188358 | SCV001355406 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-01-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001446149 | SCV001649192 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-05-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001188358 | SCV002645774 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003998950 | SCV004814677 | likely benign | Marfan syndrome | 2024-01-03 | criteria provided, single submitter | clinical testing |